HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $647,529 | -96.8% | 17,952 | -96.6% | 0.00% | -96.7% |
| Q1 2023 | $20,426,303 | +249.2% | 534,860 | +420.2% | 0.03% | +233.3% |
| Q4 2022 | $5,850,287 | +259.1% | 102,817 | +149.6% | 0.01% | +200.0% |
| Q3 2022 | $1,629,000 | -50.9% | 41,197 | -49.5% | 0.00% | -40.0% |
| Q3 2021 | $3,321,000 | -88.8% | 81,637 | -87.5% | 0.01% | -86.5% |
| Q2 2021 | $29,637,000 | +27.7% | 652,658 | +17.2% | 0.04% | +23.3% |
| Q1 2021 | $23,210,000 | +139.8% | 556,726 | +145.7% | 0.03% | +328.6% |
| Q4 2020 | $9,678,000 | +162.5% | 226,594 | +58.6% | 0.01% | +16.7% |
| Q3 2020 | $3,687,000 | +143.5% | 142,849 | +84.9% | 0.01% | +100.0% |
| Q1 2018 | $1,514,000 | -23.5% | 77,268 | -20.9% | 0.00% | 0.0% |
| Q4 2017 | $1,980,000 | – | 97,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,506,473 | $61,283,000 | 5.13% |
| First Light Asset Management, LLC | 1,477,496 | $60,105,000 | 3.96% |
| SNYDER CAPITAL MANAGEMENT L P | 3,427,476 | $139,430,000 | 3.69% |
| DOHENY ASSET MANAGEMENT /CA | 80,400 | $3,271,000 | 2.34% |
| Redwood Investments, LLC | 619,766 | $25,212,000 | 2.11% |
| HighMark Wealth Management LLC | 53,341 | $2,170,000 | 1.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 60,170 | $2,448,000 | 1.38% |
| Third Security, LLC | 168,604 | $6,859,000 | 1.33% |
| Taylor Wealth Management Partners | 87,654 | $3,566,000 | 1.27% |
| Penn Capital Management Company, LLC | 290,394 | $11,813,000 | 1.19% |